Can a One-Time cell infusion tame HIV? new trial aims to find out
NCT ID NCT04648046
First seen May 02, 2026 · Last updated May 19, 2026 · Updated 3 times
Summary
This study tests a new treatment for people with HIV that uses their own immune cells, modified in a lab to better recognize and attack the virus. About 18 participants will receive an infusion of these special cells, and then temporarily stop their HIV medications to see if the treatment can keep the virus under control. The goal is to find a safe dose and see if this approach can reduce or replace the need for daily pills.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, Davis
RECRUITINGSacramento, California, 95817, United States
Contact Email: •••••@•••••
Contact
-
Zuckerberg San Francisco General
RECRUITINGSan Francisco, California, 94110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.